CANCELLED – SECTION 71
on 08 Nov 2024
Last Applicant/ Owned by
SE-113 40 Stockholm
SE
Serial Number
79209728 filed on 23rd Mar 2017
Registration Number
5450609 registered on 24th Apr 2018
Correspondent Address
DK-1780 København V,
DENMARK
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
IMRELIX
Scientific research within the medical, pharmaceutical and bacteriological area, namely, Synthetic chemistry and generation of new chemical entities based on molecular structures of macrolides and of GnRH molecules to identify specific lead drug candidates for infectious diseases. Toxicology studies and preparation of investigational new drugs (INDs) according to good laboratory practice (GLP) sta Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of viral and infectious diseases and pharmaceutical preparations for the treatment of immune dysfunction and pharmaceutical preparations for the treatment of human immunodeficiency virus
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [044]
Medical, Beauty & Agricultural Services
Information and advice relating to pharmaceutical preparations, diseases and medical conditions and treatment, namely, information and advice on-line via computer networks or the Internet and providing information relating to prevention, diagnosis and treatment of infectious diseases and information and advice relating to diagnosis and treatment of diseases and medical disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Scientific research within the medical, pharmaceutical and bacteriological area, namely, Synthetic chemistry and generation of new chemical entities based on molecular structures of macrolides and of GnRH molecules to identify specific lead drug candidates for infectious diseases. Toxicology studies and preparation of investigational new drugs (INDs) according to good laboratory practice (GLP) standard operating procedures, analysis of pharmacokinetics and metabolism of drugs and new chemical entities, preparation of pharmaceutical formulations, high-throughput screening of new chemical entities in the field of anti-viral therapeutics, and consultancy and information relating thereto, conducting of tests regarding medical applications; packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, design and development of granulation technology and tablet technology namely, selection of lead drug candidates in the field of anti-viral therapeutics based on specific molecular structures, design of pharmaceutical and medical preparations through analysis of pharmacokinetics and metbolism of drugs and new chemical entities, manufacturing of pharmaceutical formulations according to good manufacturing practice (GMP) standard operating procedures, and consultancy and information relating thereto
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79209728
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 08th Nov 2024 | CANCELLED SECTION 71 |
| 18th Feb 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| 28th Oct 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 24th Jan 2019 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 31st Aug 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 06th Aug 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| 06th Aug 2018 | FINAL DISPOSITION PROCESSED |
| 24th Jul 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 24th Apr 2018 | REGISTERED-PRINCIPAL REGISTER |
| 06th Feb 2018 | PUBLISHED FOR OPPOSITION |